Hemostemix Inc. (CVE:HEM – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$0.10 and traded as low as C$0.10. Hemostemix shares last traded at C$0.10, with a volume of 67,017 shares traded.
Hemostemix Price Performance
The company has a current ratio of 0.04, a quick ratio of 0.48 and a debt-to-equity ratio of -55.07. The business’s fifty day moving average is C$0.10 and its 200 day moving average is C$0.11. The firm has a market capitalization of C$18.11 million, a P/E ratio of -3.70 and a beta of 0.85.
About Hemostemix
Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia.
See Also
- Five stocks we like better than Hemostemix
- How to Calculate Return on Investment (ROI)
- Quanta Services: The Backbone of the AI Data Center Push
- Investing in Travel Stocks Benefits
- Archer’s Recent String of Victories Signals a New Phase of Growth
- What is the FTSE 100 index?
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.
